A 'kitemark' that identifies randomized-controlled trials reviewed by specially trained peer reviewers would improve public trust in the robustness of clinical trials, according to an opinion piece in the open access journal BMC Medicine .
http://ift.tt/1trl56O
http://ift.tt/1trl56O
No comments:
Post a Comment